11.95USD+0.59%Mkt Cap: 882.66M USDP/E: —Last update: 2026-06-01
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat pat…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap882.66M USD
Enterprise Value611.02M USD
Revenue (TTM)97.36M USD
Gross Profit-148.16M USD
Net Income (TTM)-91.92M USD
Revenue/Share1.304 USD
Last Price11.95 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees260
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.34
PEG—
EV/EBITDA-3.03
EV/Revenue6.28
P/S9.05
P/B1.34
EPS (TTM)-2.29
EPS (Forward)-3.56
52W Range
6.92043% of range18.69
52W High18.69 USD
52W Low6.920 USD
Profitability
Gross Margin-152.18%
Oper. Margin-1724.14%
EBITDA Margin-207.27%
Profit Margin-73.20%
ROE-14.46%
ROA-10.50%
Growth
Revenue Growth-86.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-135.12M USD
CapEx (TTM)3.15M USD
FCF Margin-78.97%
FCF Yield-8.71%
Net Debt-269.79M USD
Net Debt/EBITDA1.34
Balance Sheet
Debt/Equity0.30
Current Ratio6.57
Quick Ratio6.22
Book Value/Sh8.843 USD
Cash/Share6.001 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)28.50 USD
Target Range14.00 USD – 43.00 USD
# Analysts12
Ownership
Shares Out.74.14M
Float54.48M
Insiders1.18%
Institutions115.47%
Short Interest
Short Ratio13.7d
Short % Float20.52%
Short % Out.14.45%
Shares Short10.71M
Short (prev mo.)10.31M
Technical
SMA 5012.21 (-2.1%)
SMA 20012.58 (-5.0%)
Beta0.93
S&P 52W Chg27.70%
Avg Vol (30d)687.00K
Avg Vol (10d)664.52K
Technical Indicators
RSI (14)49.1
MACD-0.2053
MACD Signal-0.2312
MACD Hist.+0.0259
BB Upper13.58 USD
BB Middle12.03 USD
BB Lower10.47 USD
BB Width25.93%
ATR (14)0.6800 USD
Vol Ratio (20d)0.41x